Customers who bought this item also bought

• Sense and Avoid in UAS. Research and Applications. Aerospace Series
• Calculus Early Transcendentals Combined, Text Book and Student Solutions Manual, 9th Edition
• The Language of Mathematics. Utilizing Math in Practice
• Practical Text Mining and Statistical Analysis for Non-structured Text Data Applications
• Effective Experimentation. For Scientists and Technologists
• Dispersion Decay and Scattering Theory
• Dispersion Decay and Scattering Theory
• Visual Data Mining. The VisMiner Approach
• How to be a Quantitative Ecologist. The 'A to R' of Green Mathematics and Statistics
• The Design and Management of Medical Device Clinical Trials. Strategies and Challenges

S&P Acts on Indonesian Banks Following IBRA Action Apr 98. Edition No. 1

VDM Publishing House, March 2010, Pages: 60

This study experimentally tested the ability of normal participants and patients with schizophrenia to encode the direction of eye gaze using a novel Inhibition of Return (IOR) gaze-direction paradigm. All participants were administered a standard IOR paradigm and a gaze-evoked IOR task. IOR effects were predicted for control participants in both tasks but for participants with schizophrenia, IOR effects were predicted in the standard IOR task but not the gaze evoked task due to social cognition impairments found in people with schizophrenia. Results demonstrated that the IOR effect of slower responses to targets appearing at previously-cued locations compared to targets appearing at uncued locations was present for normal participants in attentional test conditions using both standard and gaze IOR paradigms. In patients with schizophrenia, however, a reduced IOR effect was evident in the gaze task, but not the standard task, when compared to controls. The results suggested disturbances in the ability to encode the direction of eye gaze in schizophrenia, which is thought to represent a key component of perceiving and understanding the intentions and actions of others.

Kristy, Klein.
Kristy Klein received her Ph.D. in Clinical Psychology in 2010 from the University of Massachusetts, Boston. Her interests include the social, cognitive, and affective neurosciences of attention, memory, and intelligence as applied to clinical disorders, particularly schizophrenia.